HomeHYL • EBR
add
Hyloris Pharmaceuticals SA
Nakaraang pagsara
€6.72
Sakop ng araw
€6.49 - €6.70
Sakop ng taon
€2.89 - €12.35
Market cap
191.67M EUR
Average na Volume
16.66K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Mga balita tungkol sa merkado
Investor's Business Daily
4 oras ang nakalipas
Market Focus Still On Tariffs; Tesla Leads Key Earnings
1.33%
0.92%
0.070%
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.70M | 76.88% |
Gastos sa pagpapatakbo | 3.71M | -37.24% |
Net na kita | -1.43M | 67.33% |
Net profit margin | -52.89 | 81.53% |
Kita sa bawat share | — | — |
EBITDA | -609.50K | 86.11% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 24.15M | -21.86% |
Kabuuang asset | 41.34M | -13.31% |
Kabuuang sagutin | 9.19M | 6.73% |
Kabuuang equity | 32.14M | — |
Natitirang share | — | — |
Presyo para makapag-book | — | — |
Return on assets | -6.49% | — |
Return on capital | -7.90% | — |
Cash Flow
Net change in cash
| (EUR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.43M | 67.33% |
Cash mula sa mga operasyon | -1.68M | 61.40% |
Cash mula sa pag-invest | -63.50K | -101.27% |
Cash mula sa financing | -179.50K | -603.92% |
Net change in cash | -1.92M | -407.87% |
Malayang cash flow | -223.19K | 92.06% |
Tungkol
Itinatag
2012
Website
Mga Empleyado
49
